Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial

2009 ◽  
Vol 2009 ◽  
pp. 208-209
Author(s):  
B.L. Clarke
Keyword(s):  
Clinical Trial ◽  
Vertebral Fracture ◽  
Fracture Risk ◽  
Postmenopausal Women ◽  
Controlled Clinical Trial ◽  
Vertebral Fracture Risk

Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index

Bone ◽  
2005 ◽  
Vol 37 (2) ◽  
pp. 170-174 ◽  
Author(s):  
Harry K. Genant ◽  
Ethel Siris ◽  
Gerald G. Crans ◽  
Durisala Desaiah ◽  
John H. Krege
Keyword(s):  
Vertebral Fracture ◽  
Fracture Risk ◽  
Postmenopausal Women ◽  
Spinal Deformity ◽  
Vertebral Fracture Risk ◽  
Spinal Deformity Index

scholarly journals Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis

2004 ◽  
Vol 164 (18) ◽  
pp. 2024 ◽  
Author(s):  
Robert Lindsay ◽  
Wim H. Scheele ◽  
Robert Neer ◽  
Gerhardt Pohl ◽  
Silvano Adami ◽  
...  
Keyword(s):  
Vertebral Fracture ◽  
Fracture Risk ◽  
Postmenopausal Women ◽  
Risk Reduction ◽  
Vertebral Fracture Risk ◽  
Fracture Risk Reduction

Vertebral fracture risk (VFR) score for fracture prediction in postmenopausal women

2010 ◽  
Vol 22 (7) ◽  
pp. 2119-2128 ◽  
Author(s):  
M. Lillholm ◽  
A. Ghosh ◽  
P. C. Pettersen ◽  
M. de Bruijne ◽  
E. B. Dam ◽  
...  
Keyword(s):  
Vertebral Fracture ◽  
Fracture Risk ◽  
Postmenopausal Women ◽  
Fracture Prediction ◽  
Vertebral Fracture Risk
Sign in / Sign up

Export Citation Format

Share Document